IN8Bio Competitors and Similar CompaniesClear all
IN8Bio's competitors and similar companies include Aura Biosciences and OBI Pharma.
 IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer. |  Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. | ||
Founding Date | Founding Date 2016 | Founding Date 2009 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Birmingham, US | Locations Cambridge, US HQ | Locations TW HQ San Diego, US |
Employees | Employees 13 | Employees 42 | Employees 124 |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) 544.2 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($19.4m) (FY, 2025) | Net income ($106.2m) (FY, 2025) | Net income (NT$2.5b) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 213.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Aura Biosciences
HQ
Cambridge, US
Employees
42
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View company
OBI Pharma
HQ
TW
Employees
124
OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View company